Can't say I know this one all that well. Rightly or wrongly, I'm generally a bit wary of P3 binaries in general and especially when it pertains to a dermatological indication (quite often high placebo responses). As far as the follow-on JAK programs, there are others working in this space, correct? I recall an obscure Australian small-cap biotech that I believe was working on a JAK program for alopecia (would have to dig to recall but I generally don't trust Australian small-cap biotechs anyways).